.
.
torsdag, juni 22, 2017
Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older — NEJM
Click -->
Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older — NEJM
: Original Article from The New England Journal of Medicine —
‹
›
Startsida
Visa webbversion